S&P 500   4,050.83
DOW   32,859.03
QQQ   315.68
Is SoFi Technologies a Buy in the Midst of a Banking Crisis?
Unusual Passive Income Investment (Found on a Golf Course) (Ad)
3 Companies That Just Started Paying Dividends
CloudFlare's Chart Shows Bullish Moving-Average Crossover
Unusual Passive Income Investment (Found on a Golf Course) (Ad)
The Squeeze Is On For EVGo, Rally To Follow 
Alibaba Just Changed The Game For Chinese Tech Conglomerates
Unusual Passive Income Investment (Found on a Golf Course) (Ad)
Analysts Upgrade Ciena Corp to Strong Buy
Closing prices for crude oil, gold and other commodities
S&P 500   4,050.83
DOW   32,859.03
QQQ   315.68
Is SoFi Technologies a Buy in the Midst of a Banking Crisis?
Unusual Passive Income Investment (Found on a Golf Course) (Ad)
3 Companies That Just Started Paying Dividends
CloudFlare's Chart Shows Bullish Moving-Average Crossover
Unusual Passive Income Investment (Found on a Golf Course) (Ad)
The Squeeze Is On For EVGo, Rally To Follow 
Alibaba Just Changed The Game For Chinese Tech Conglomerates
Unusual Passive Income Investment (Found on a Golf Course) (Ad)
Analysts Upgrade Ciena Corp to Strong Buy
Closing prices for crude oil, gold and other commodities
S&P 500   4,050.83
DOW   32,859.03
QQQ   315.68
Is SoFi Technologies a Buy in the Midst of a Banking Crisis?
Unusual Passive Income Investment (Found on a Golf Course) (Ad)
3 Companies That Just Started Paying Dividends
CloudFlare's Chart Shows Bullish Moving-Average Crossover
Unusual Passive Income Investment (Found on a Golf Course) (Ad)
The Squeeze Is On For EVGo, Rally To Follow 
Alibaba Just Changed The Game For Chinese Tech Conglomerates
Unusual Passive Income Investment (Found on a Golf Course) (Ad)
Analysts Upgrade Ciena Corp to Strong Buy
Closing prices for crude oil, gold and other commodities
S&P 500   4,050.83
DOW   32,859.03
QQQ   315.68
Is SoFi Technologies a Buy in the Midst of a Banking Crisis?
Unusual Passive Income Investment (Found on a Golf Course) (Ad)
3 Companies That Just Started Paying Dividends
CloudFlare's Chart Shows Bullish Moving-Average Crossover
Unusual Passive Income Investment (Found on a Golf Course) (Ad)
The Squeeze Is On For EVGo, Rally To Follow 
Alibaba Just Changed The Game For Chinese Tech Conglomerates
Unusual Passive Income Investment (Found on a Golf Course) (Ad)
Analysts Upgrade Ciena Corp to Strong Buy
Closing prices for crude oil, gold and other commodities
NASDAQ:BWAY

BrainsWay - BWAY Competitors

$1.64
-0.05 (-2.95%)
(As of 03/30/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.65
$1.74
50-Day Range
$1.65
$2.25
52-Week Range
$1.64
$9.18
Volume
56,924 shs
Average Volume
86,054 shs
Market Capitalization
$27.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.25

BWAY vs. VAPO, LNSR, ICU, NMRD, NMTC, AFIB, PAVM, TNON, SSKN, and VERO

Should you be buying BrainsWay stock or one of its competitors? The main competitors of BrainsWay include Vapotherm (VAPO), LENSAR (LNSR), SeaStar Medical (ICU), Nemaura Medical (NMRD), NeuroOne Medical Technologies (NMTC), Acutus Medical (AFIB), PAVmed (PAVM), Tenon Medical (TNON), STRATA Skin Sciences (SSKN), and Venus Concept (VERO). These companies are all part of the "surgical & medical instruments" industry.

BrainsWay vs.

BrainsWay (NASDAQ:BWAY) and Vapotherm (NYSE:VAPO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, community ranking, media sentiment and institutional ownership.

In the previous week, BrainsWay had 8 more articles in the media than Vapotherm. MarketBeat recorded 9 mentions for BrainsWay and 1 mentions for Vapotherm. Vapotherm's average media sentiment score of 0.23 beat BrainsWay's score of 0.06 indicating that Vapotherm is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrainsWay
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Neutral
Vapotherm
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

BrainsWay presently has a consensus target price of $7.25, suggesting a potential upside of 340.73%. Vapotherm has a consensus target price of $4.75, suggesting a potential upside of 703.04%. Given Vapotherm's higher possible upside, analysts plainly believe Vapotherm is more favorable than BrainsWay.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrainsWay
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Vapotherm
1 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.80

BrainsWay has a beta of 0.97, meaning that its share price is 3% less volatile than the S&P 500. Comparatively, Vapotherm has a beta of -1.08, meaning that its share price is 208% less volatile than the S&P 500.

BrainsWay has a net margin of -49.12% compared to Vapotherm's net margin of -169.55%. BrainsWay's return on equity of -26.22% beat Vapotherm's return on equity.

Company Net Margins Return on Equity Return on Assets
BrainsWay -49.12% -26.22% -19.27%
Vapotherm -169.55% -1,250.70% -68.14%

BrainsWay has higher earnings, but lower revenue than Vapotherm. BrainsWay is trading at a lower price-to-earnings ratio than Vapotherm, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrainsWay$27.18 million1.00-$13.35 million-$0.40-4.11
Vapotherm$66.80 million0.41-$113.26 million-$4.24-0.14

47.9% of BrainsWay shares are owned by institutional investors. Comparatively, 59.0% of Vapotherm shares are owned by institutional investors. 19.0% of BrainsWay shares are owned by company insiders. Comparatively, 10.6% of Vapotherm shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Vapotherm received 33 more outperform votes than BrainsWay when rated by MarketBeat users. However, 63.95% of users gave BrainsWay an outperform vote while only 54.32% of users gave Vapotherm an outperform vote.

CompanyUnderperformOutperform
BrainsWayOutperform Votes
55
63.95%
Underperform Votes
31
36.05%
VapothermOutperform Votes
88
54.32%
Underperform Votes
74
45.68%

Summary

BrainsWay beats Vapotherm on 12 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BWAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BWAY vs. The Competition

MetricBrainsWaySurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$27.21M$3.37B$4.38B$5.94B
Dividend YieldN/A3.11%2.40%4.51%
P/E Ratio-4.11105.70156.6715.88
Price / Sales1.0035.873,540.5459.58
Price / CashN/A62.9726.9870.12
Price / Book0.604.414.565.05
Net Income-$13.35M$57.23M$115.24M$191.52M
7 Day Performance-12.03%-0.12%1.15%1.50%
1 Month Performance-15.21%-4.05%-6.56%-5.18%
1 Year Performance-81.16%-25.96%-14.73%-16.77%

BrainsWay Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VAPO
Vapotherm
1.8952 of 5 stars
$0.59
flat
$4.75
+704.9%
-95.9%$27.26M$66.80M-0.14510Gap Up
LNSR
LENSAR
0 of 5 stars
$2.41
flat
$14.00
+480.9%
-67.9%$26.75M$35.36M-1.22110Positive News
Gap Up
ICU
SeaStar Medical
0 of 5 stars
$2.02
-1.9%
N/AN/A$26.10MN/A0.00N/ANews Coverage
Positive News
Gap Up
NMRD
Nemaura Medical
2.4206 of 5 stars
$0.90
+3.5%
$6.50
+624.5%
-80.1%$25.93M$500,000.00-1.6025Positive News
NMTC
NeuroOne Medical Technologies
1.0067 of 5 stars
$1.55
+1.3%
$2.63
+69.4%
+41.1%$25.36M$252,000.00-2.772,019
AFIB
Acutus Medical
2.1167 of 5 stars
$0.70
-6.7%
$2.00
+187.8%
-61.2%$21.44M$16.36M-0.44291Short Interest ↑
High Trading Volume
PAVM
PAVmed
1.8592 of 5 stars
$0.36
-2.7%
$3.56
+903.5%
-73.7%$34.94M$380,000.00-0.3525
TNON
Tenon Medical
2.1208 of 5 stars
$1.86
+6.9%
$6.00
+222.6%
N/A$20.93M$690,000.00-0.468Short Interest ↓
SSKN
STRATA Skin Sciences
1.701 of 5 stars
$1.07
+4.9%
$2.00
+86.9%
-21.7%$37.15M$29.98M-6.29115Positive News
VERO
Venus Concept
2.0918 of 5 stars
$0.23
+14.9%
$5.50
+2,281.0%
-85.3%$17.07M$105.62M-0.39407Earnings Report
Analyst Report
Gap Up
This page (NASDAQ:BWAY) was last updated on 3/31/2023 by MarketBeat.com Staff